Chronic Coronary Artery Disease Management - Dr Cutlip.pdf

More documents

Recommendations

Info

FREEDOM Results Primary Endpoint All-Cause Mortality M Farkouh et al. NEJM 2012 ; 11/4/12 HARVARD CLINICAL RESEARCH INSTITUTE
BARI RCT: Relationship between IMA graft and Mortality Non-Diabetics Treated Diabetics 30% 30% 20% 20% 20.6% 18.2% 10% 10% 4.6% 5.4% 4.8% 0% CABG +IMA CABG SVG only PTCA 0% 2.8% CABG +IMA CABG SVG only PTCA
Page 1 and 2: Cardiovascular Disease and Diabetes
Page 3 and 4: Prevalence Diabetes - A Cardiovascu
Page 5 and 6: Hallmarks of Diabetic Coronary Arte
Page 7 and 8: Diabetes and Coronary Thrombosis
Page 9 and 10: Screen Asymptomatic DM Patients?
Page 11 and 12: Screen Asymptomatic DM Patients? Up
Page 13 and 14: Step 1- Prevention Diabetes and Pat
Page 15 and 16: Why Does Intensive Glycemic Control
Page 17 and 18: BARI 2D - Glycemic Control Strategy
Page 19 and 20: Diabetes and Coronary Disease The R
Page 21 and 22: Role of Intensive Therapy What is t
Page 23 and 24: Targeting Diabetic Dyslipidemia Is
Page 25 and 26: Medical Therapy of CAD • Risk fac
Page 27 and 28: Medical Rx vs Revascularization Imp
Page 29 and 30: Medical Therapy versus CABG BARI-2D
Page 31 and 32: Ischemia Reduction in COURAGE Impac
Page 33 and 34: FAME II Trial N=888 randomized FFR
Page 35 and 36: Diabetic Patients With Multivessel
Page 37: FREEDOM Trial Design (2) Design: Su
Page 41 and 42: Assessment and Treatment of CAD Pro
Page 43: Conclusions • CAD is prevalent am

Chronic Coronary Artery Disease Management - Dr Cutlip.pdf

Create successful ePaper yourself

Delete template?

Save as template?